Multifactorial analysis of willingness to undergo subcutaneous allergen immunotherapy in pediatric patients

Bo Ding1, Jie Zhong2, Chun Jiang3

  • 1Bo Ding, Department of Pediatrics, Renji Hospital Affiliated to, Shanghai JiaoTong University School of Medicine, 2000 Jiangyue Road, Shanghai 201112, P.R. China.

Insights

Pediatric patients

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Public Health

Background:

  • Allergic respiratory diseases significantly impact children's quality of life.
  • Allergen immunotherapy (AIT) offers a disease-modifying treatment option.
  • Understanding factors influencing AIT acceptance is crucial for improving treatment adherence.

Purpose of the Study:

  • To identify key factors influencing the acceptance of allergen immunotherapy (AIT) among pediatric patients and their families.
  • To explore the relationship between disease characteristics, parental knowledge, and physician recommendations on AIT willingness.
  • To provide insights for enhancing AIT adoption in pediatric allergy care.

Main Methods:

  • A survey of 406 pediatric patients (ages not specified) with allergic respiratory diseases was conducted.
  • An online questionnaire assessed patient demographics, allergic disease status, family history, parental knowledge, and physician recommendations.
  • Statistical analyses, including univariate and multifactorial logistic regression, were used to identify significant influencing factors.

Main Results:

  • Factors significantly associated with AIT willingness included allergic rhinitis (AR) severity, asthma (AS) severity, parental knowledge of allergic diseases, and physician recommendation (p < 0.05).
  • Multifactorial analysis confirmed that AR/AS severity, parental knowledge, and doctor's recommendation were independent predictors of AIT acceptance.
  • Other factors like drug allergy, severe reaction history, mother's education, and distance to hospital showed statistical differences but were not independent predictors in the final model.

Conclusions:

  • The severity of allergic rhinitis and asthma, coupled with parental understanding and physician endorsement, are critical determinants of pediatric AIT acceptance.
  • Targeted patient education and strong physician recommendations can significantly improve willingness to undergo AIT for pediatric allergic respiratory diseases.
  • Addressing parental knowledge gaps and clearly communicating the benefits of AIT are essential for successful treatment implementation in children.
Abstract